Home/Filings/4/0001127602-14-009658
4//SEC Filing

LEXICON PHARMACEUTICALS, INC./DE 4

Accession 0001127602-14-009658

$LXRXCIK 0001062822operating

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 6:20 PM ET

Size

17.3 KB

Accession

0001127602-14-009658

Insider Transaction Report

Form 4
Period: 2014-02-28
SANDS ARTHUR T
DirectorPres & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2014-02-28+37,0001,016,120 total
  • Exercise/Conversion

    Restricted Stock Units (Phantom Stock)

    2014-02-2836,25036,250 total
    Common Stock (36,250 underlying)
  • Exercise/Conversion

    Restricted Stock Units (Phantom Stock)

    2014-02-2835,000105,000 total
    Common Stock (35,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-02-28+36,250979,120 total
  • Exercise/Conversion

    Common Stock

    2014-02-28+35,0001,051,120 total
  • Tax Payment

    Common Stock

    2014-02-28$1.92/sh29,791$57,1991,021,329 total
  • Exercise/Conversion

    Restricted Stock Units (Phantom Stock)

    2014-02-2837,00074,000 total
    Common Stock (37,000 underlying)
Holdings
  • Common Stock

    (indirect: By Sands Associates L.P.)
    817,500
  • Common Stock

    (indirect: By Spouse)
    60,000
Footnotes (5)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
  • [F3]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2012 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
  • [F4]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2013 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
  • [F5]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

Issuer

LEXICON PHARMACEUTICALS, INC./DE

CIK 0001062822

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001062822

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:20 PM ET
Size
17.3 KB